Mirae Asset Global Investments Co., Ltd. Alnylam Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,775 shares of ALNY stock, worth $2.15 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,775
Previous 6,534
26.92%
Holding current value
$2.15 Million
Previous $1.76 Million
11.73%
% of portfolio
0.01%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding ALNY
# of Institutions
806Shares Held
116MCall Options Held
584KPut Options Held
648K-
Capital World Investors Los Angeles, CA16.8MShares$7.55 Billion0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$5.98 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.29 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.19MShares$3.23 Billion0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.28MShares$1.92 Billion0.88% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $55.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...